Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 37,500 | |||
5 mg | 在庫あり | ¥ 92,000 | |||
10 mg | 在庫あり | ¥ 138,000 | |||
25 mg | 在庫あり | ¥ 220,000 | |||
50 mg | 在庫あり | ¥ 294,000 | |||
100 mg | 在庫あり | ¥ 402,000 |
説明 | BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer. |
In vivo | Sixty-one men with CRPC were treated with daily BMS-641988 (5 to 150 mg). Seventeen of 23 evaluable patients (74%) exhibited stable disease on imaging (median 15 weeks; range 8-32), and 10 of 61 patients (16%) achieved a ≥ 30% decline in levels of prostate-specific antigen (PSA).[1] |
分子量 | 471.45 |
分子式 | C20H20F3N3O5S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (95.45 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-641988 Endocrinology/Hormones Androgen Receptor Inhibitor inhibitor inhibit